West Pharmaceutical Services Inc. (WST) Shares Sold by Advisors Asset Management Inc.

Advisors Asset Management Inc. lessened its stake in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 35.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 13,558 shares of the medical instruments supplier’s stock after selling 7,339 shares during the period. Advisors Asset Management Inc.’s holdings in West Pharmaceutical Services were worth $1,346,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in WST. Bessemer Group Inc. raised its position in shares of West Pharmaceutical Services by 13,849.8% during the 2nd quarter. Bessemer Group Inc. now owns 950,816 shares of the medical instruments supplier’s stock worth $94,407,000 after purchasing an additional 944,000 shares during the last quarter. USS Investment Management Ltd raised its position in shares of West Pharmaceutical Services by 24.6% during the 2nd quarter. USS Investment Management Ltd now owns 1,087,078 shares of the medical instruments supplier’s stock worth $107,936,000 after purchasing an additional 214,707 shares during the last quarter. Janus Henderson Group PLC raised its position in shares of West Pharmaceutical Services by 27.1% during the 2nd quarter. Janus Henderson Group PLC now owns 875,723 shares of the medical instruments supplier’s stock worth $86,951,000 after purchasing an additional 186,752 shares during the last quarter. Millennium Management LLC raised its position in shares of West Pharmaceutical Services by 361.5% during the 1st quarter. Millennium Management LLC now owns 194,693 shares of the medical instruments supplier’s stock worth $17,189,000 after purchasing an additional 152,508 shares during the last quarter. Finally, Cornerstone Wealth Management LLC acquired a new position in shares of West Pharmaceutical Services during the 2nd quarter worth about $1,411,000. Hedge funds and other institutional investors own 93.64% of the company’s stock.

Several research firms recently weighed in on WST. Zacks Investment Research upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $123.00 price target for the company in a research report on Tuesday, July 31st. ValuEngine upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating in a research report on Wednesday, October 17th.



WST opened at $105.92 on Thursday. West Pharmaceutical Services Inc. has a twelve month low of $82.74 and a twelve month high of $125.09. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.67 and a quick ratio of 1.94. The stock has a market cap of $7.44 billion, a P/E ratio of 38.10, a P/E/G ratio of 3.83 and a beta of 1.16.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings data on Thursday, October 25th. The medical instruments supplier reported $0.76 EPS for the quarter, beating the Zacks’ consensus estimate of $0.70 by $0.06. The company had revenue of $431.70 million during the quarter, compared to the consensus estimate of $427.55 million. West Pharmaceutical Services had a net margin of 9.06% and a return on equity of 15.97%. On average, sell-side analysts expect that West Pharmaceutical Services Inc. will post 2.8 earnings per share for the current fiscal year.

In other West Pharmaceutical Services news, SVP Karen Flynn sold 20,458 shares of the stock in a transaction dated Tuesday, August 7th. The shares were sold at an average price of $116.23, for a total value of $2,377,833.34. Following the completion of the sale, the senior vice president now owns 31,051 shares in the company, valued at approximately $3,609,057.73. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.70% of the stock is currently owned by corporate insiders.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

See Also: What are defining characteristics of a correction?

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply